BioInvent to host Key Opinion Leader call on BI-1206 for relapsed or refractory Non-Hodgkin’s Lymphoma

20. Januar 2021 INDIZES WEUR

LUND, Sweden, Jan. 20, 2021 /PRNewswire/ — BioInvent International AB (“BioInvent”) (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modula …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...